Fireside Chat: Impact of Innovative Treatments for Rare Pediatric Diseases

2:40 PM - 3:15 PM (EDT), Thursday, October 29, 2020
Join us for a fireside chat moderated by Jeremy Levin, Chairman & CEO, Ovid Therapeutics, with Terry Jo Bichell, Executive Director, Combined Brain and Rebecca Burdine, Professor of Molecular Biology at Princeton University to hear the unique experience and lessons learned on forming a patient advocacy organization focusing on a rare disease.
Moderator
photo
Chairman & CEO
Ovid Therapeutics Inc.
Speakers
photo
Executive Director
Combined Brain
photo
Professor of Molecular Biology
Princeton University
photo
Chairman & CEO
Ovid Therapeutics Inc.